Skip to content

Drug interactions

Olaparib + Tocilizumab

Severity: Moderate

Olaparib and Tocilizumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Olaparib commonly causes anaemia, neutropenia and thrombocytopenia, and tocilizumab can reduce neutrophil and platelet counts and impair infection defences. Combined use could increase the risk of cytopenias and infection.

What this interaction means in plain words

Olaparib and Tocilizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Olaparib belongs to Oncology; Tocilizumab belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Additive myelosuppression and immunosuppression; no pharmacokinetic interaction is known.

What to do

Monitor complete blood counts regularly and manage infections promptly. Interrupt or reduce the dose of either drug if significant neutropenia develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Olaparib and Tocilizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Olaparib with Tocilizumab?

MediHelp rates the interaction as moderate. Olaparib and Tocilizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Olaparib commonly causes anaemia, neutropenia and thrombocytopenia, and tocilizumab can reduce neutrophil and platelet counts and impair infection defences. Combined use could increase the risk of cytopenias and infection.

How serious is the interaction between Olaparib and Tocilizumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts regularly and manage infections promptly. Interrupt or reduce the dose of either drug if significant neutropenia develops.

What other medicines interact with Tocilizumab?

MediHelp also lists interactions of Tocilizumab with, for example, Bcg vaccine live, Measles mumps and rubella vaccine live, Measles mumps rubella and varicella vaccine live. The full list is on the Tocilizumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in